WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
WMCH GLOBAL (08208) will be suspended from trading starting from November 7th, awaiting the publication of insider information.
WMCH GLOBAL (08208) will be temporarily suspended from trading starting from November 7th.
Securities Morning Meeting Highlights | Quantum computing is currently at a crucial turning point from scientific breakthroughs to commercialization.
WMCH GLOBAL (08208) will be suspended from trading starting from November 7th, awaiting the publication of insider information.
WMCH GLOBAL (08208) will be temporarily suspended from trading starting from November 7th.
Securities Morning Meeting Highlights | Quantum computing is currently at a crucial turning point from scientific breakthroughs to commercialization.
RECOMMEND
SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025
Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025
National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025
